Related Experiment Video
Updated: Aug 14, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study
Keiko I Greenberg1, Mara A McAdams-DeMarco2, Anna Köttgen3
1Departments of Medicine and kgreenb4@jhmi.edu.
Insights
Higher plasma urate levels are linked to an increased risk of acute kidney injury (AKI). However, genetic analysis did not confirm urate as a direct cause of AKI, suggesting further research is needed.
Area of Science:
- Nephrology
- Cardiovascular Disease Epidemiology
- Genetic Epidemiology
Background:
- Elevated serum urate is a known risk factor for chronic kidney disease (CKD).
- The association between serum urate and acute kidney injury (AKI) is less understood.
- This study investigates the relationship between urate levels and hospitalized AKI risk.
Purpose of the Study:
- To evaluate the association between plasma urate concentrations and the risk of hospitalized AKI.
- To explore the potential causal role of urate in kidney injury using genetic data.
- To examine interactions between urate, gout, and CKD in relation to AKI risk.
Main Methods:
- A large population-based cohort (Atherosclerosis Risk in Communities study) with 11,011 participants followed for 12 years.
- Cox regression analysis was used to assess the association between baseline plasma urate and AKI risk, adjusting for covariates.
- Mendelian randomization with a genetic urate score was employed to infer causality.
Main Results:
- Higher plasma urate (>5.0 mg/dl) was independently associated with an increased risk of hospitalized AKI (HR 1.16 per 1 mg/dl increase).
- The urate-AKI association was significant only in participants without a history of gout (P=0.02).
- No significant association was found between a genetic urate score and AKI risk, indicating a lack of causal evidence.
Conclusions:
- Plasma urate levels above 5.0 mg/dl are independently associated with a higher risk of hospitalized AKI.
- Genetic evidence does not support a causal role for urate in AKI.
- Further research is warranted to determine if urate-lowering therapies can reduce AKI risk.
Background And Objectives:
Higher urate levels are associated with higher risk of CKD, but the association between urate and AKI is less established. This study evaluated the risk of hospitalized AKI associated with urate concentrations in a large population-based cohort. To explore whether urate itself causes kidney injury, the study also evaluated the relationship between a genetic urate score and AKI.
Design, Setting, Participants, & Measurements:
A total of 11,011 participants from the Atherosclerosis Risk in Communities study were followed from 1996-1998 (baseline) to 2010. The association between baseline plasma urate and risk of hospitalized AKI, adjusted for known AKI risk factors, was determined using Cox regression. Interactions of urate with gout and CKD were tested. Mendelian randomization was performed using a published genetic urate score among the participants with genetic data (n=7553).
Results:
During 12 years of follow-up, 823 participants were hospitalized with AKI. Overall, mean participant age was 63.3 years, mean eGFR was 86.3 ml/min per 1.73 m(2), and mean plasma urate was 5.6 mg/dl. In patients with plasma urate >5.0 mg/dl, there was a 16% higher risk of hospitalized AKI for each 1-mg/dl higher urate (adjusted hazard ratio, 1.16; 95% confidence interval, 1.10 to 1.23; P<0.001). When stratified by history of gout, the association between higher urate and AKI was significant only in participants without a history of gout (P for interaction=0.02). There was no interaction of CKD and urate with AKI, nor was there an association between genetic urate score and AKI.
Conclusions:
Plasma urate >5.0 mg/dl was independently associated with risk of hospitalized AKI; however, Mendelian randomization did not provide evidence for a causal role of urate in AKI. Further research is needed to determine whether lowering plasma urate might reduce AKI risk.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management